Skip to main content
Fig. 4 | BMC Complementary Medicine and Therapies

Fig. 4

From: Biochanin A abrogates osteoclastogenesis in type 2 diabetic osteoporosis via regulating ROS/MAPK signaling pathway based on integrating molecular docking and experimental validation

Fig. 4

BCA reduces ROS levels induced by RANKL. A Representative fluorescence microscope images of BMMs stained for DCFH‑DA (Scale bars = 200 μm). B Representative histogram images of BMMs indicated that the mean fluorescence intensity was analyzed by flow cytometry; the images include osteoclasts treated with RANKL and 0, 5 and 10µM BCA

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us